Cannabis Stock Movers For August 29, 2023

GAINERS: Blueberries Medical (OTC:BBRRF) shares closed up 49.36% at $0.02 Tetra Bio Pharma (OTC:TBPMF) shares closed up 25.00%…

GAINERS:

  • Blueberries Medical (OTC:BBRRF) shares closed up 49.36% at $0.02
  • Tetra Bio Pharma (OTC:TBPMF) shares closed up 25.00% at $0.00
  • Item 9 Labs (OTC:INLB) shares closed up 25.00% at $0.01
  • Nextleaf Solutions (OTC:OILFF) shares closed up 20.90% at $0.04
  • CNBX Pharmaceuticals (OTC:CNBX) shares closed up 17.67% at $0.02
  • Trees (OTC:CANN) shares closed up 16.49% at $0.08
  • MariMed (OTC:MRMD) shares closed up 13.40% at $0.33
  • MJ Holdings (OTC:MJNE) shares closed up 11.11% at $0.01
  • Kaya Holdings (OTC:KAYS) shares closed up 10.00% at $0.05
  • Cannabix Technologies (OTC:BLOZF) shares closed up 9.89% at $0.20
  • Greenlane Hldgs (NASDAQ:GNLN) shares closed up 9.86% at $0.77
  • iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 8.46% at $0.01
  • GreenGro Technologies (OTC:GRNH) shares closed up 7.69% at $0.00
  • Leafbuyer Techs (OTC:LBUY) shares closed up 7.17% at $0.06
  • CLS Holdings USA (OTC:CLSH) shares closed up 7.14% at $0.07
  • Elixinol Wellness (OTC:ELLXF) shares closed up 6.67% at $0.01
  • Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed up 5.47% at $7.14
  • Auxly Cannabis Group (OTC:CBWTF) shares closed up 4.35% at $0.01
  • Genetic Technologies (NASDAQ:GENE) shares closed up 3.99% at $0.73
  • MedMen Enterprises (OTC:MMNFF) shares closed up 3.03% at $0.02

LOSERS:

  • EVIO (OTC:EVIO) shares closed down 50.00% at $0.00
  • AusCann Group Holdings (OTC:ACNNF) shares closed down 49.04% at $0.00
  • 1933 Industries (OTC:TGIFF) shares closed down 18.15% at $0.01
  • Neptune Wellness Solns (NASDAQ:NEPT) shares closed down 7.51% at $0.14
  • Body and Mind (OTC:BMMJ) shares closed down 4.96% at $0.06
  • CV Sciences (OTC:CVSI) shares closed down 4.89% at $0.04
  • 22nd Century Group (NASDAQ:XXII) shares closed down 3.95% at $1.70

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Verve Therapeutics Announced VERVE-101 Awarded Innovation Passport By UK MHRA For Treatment Of Heterozygous Familial Hypercholesterolemia

Verve Therapeutics, Inc. today announced that VERVE-101 has been awarded the Innovation Passport for the treatment of heterozygous familial hypercholesterolemia (HeFH) under the Innovative Licensing and Access Pathway (ILAP) by the Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory body of the United Kingdom (UK).

VERV